Ibraheem Anas
Internal Medicine, Imamein Kadhimein Medical City, Baghdad, IRQ.
Cureus. 2023 Mar 27;15(3):e36735. doi: 10.7759/cureus.36735. eCollection 2023 Mar.
β-thalassemia major (β-TM) is an inherited autosomal recessive disorder manifested by the hemoglobin β chain synthesis alteration. It is a lifelong illness with a scope of a wide range of complications. Many kinds of literature evaluated the effect of Ramadan intermittent fasting (RIF) on different medical conditions. However, there are no precise guidelines regarding its effect on patients with β-TM.
A retrospective cohort study was conducted on β-TM patients who visited the hereditary blood disorder center at Al Karama Teaching Hospital in Baghdad. Accordingly, six parameters were used to evaluate the effect of RIF on β-TM patients before, during, and after Ramadan. These parameters include hemoglobin level, frequency of transfusion, aspartate aminotransferase (AST) level, alanine aminotransferase (ALT) level, left ventricular ejection fraction % (EF%), and spleen size. All of these details, including the demographic characteristics of age, gender, history of splenectomy, and body mass index (BMI) were retrieved from the patient's medical records after confirming their fasting through one-to-one interviews. This study aimed to fill the gap and investigate the possible effect of RIF on the severity of β-TM.
A total of 184 β-TM patients were enrolled in this study. The mean duration of fasting was 25.2±2.18 days. More than half (110) of the patients were females (59.8%). Whereas, the mean age was 24.8±3.5 years. One-third of the patients (65) had a splenectomy (35.3%) and more than two-thirds had normal BMI. The initial parameters used to score the severity of β-TM were evaluated separately. As a result, the hemoglobin level remained steady without any statistical significance during the three months. In addition, the frequency of blood transfusion and the spleen size carried the same result. Although the lowest median and range of liver enzymes were recorded during Ramadan, they were statistically insignificant compared to pre and post-fasting. Moreover, the left ventricular EF% was insignificant regardless of the patient's history of heart disease.
This study revealed that RIF does not seem to affect the severity of β-TM if the patients proceed with fasting. However, further studies in more countries with a bigger sample size are recommended to confirm these findings.
重型β地中海贫血(β-TM)是一种常染色体隐性遗传性疾病,表现为血红蛋白β链合成改变。它是一种终身疾病,会引发一系列并发症。许多文献评估了斋月间歇性禁食(RIF)对不同疾病的影响。然而,关于其对β-TM患者的影响,尚无确切指南。
对前往巴格达卡拉马教学医院遗传性血液疾病中心就诊的β-TM患者进行了一项回顾性队列研究。据此,使用六个参数评估斋月前、斋月期间和斋月后RIF对β-TM患者的影响。这些参数包括血红蛋白水平、输血频率、天冬氨酸转氨酶(AST)水平、丙氨酸转氨酶(ALT)水平、左心室射血分数(EF%)和脾脏大小。在通过一对一访谈确认患者禁食后,所有这些细节,包括年龄、性别、脾切除病史和体重指数(BMI)等人口统计学特征,均从患者病历中获取。本研究旨在填补空白,调查RIF对β-TM严重程度的可能影响。
本研究共纳入184例β-TM患者。平均禁食时长为25.2±2.18天。超过半数(110例)患者为女性(59.8%)。平均年龄为24.8±3.5岁。三分之一的患者(65例)接受过脾切除术(35.3%),超过三分之二的患者BMI正常。分别对用于评估β-TM严重程度的初始参数进行了评估。结果显示,三个月内血红蛋白水平保持稳定,无统计学意义。此外,输血频率和脾脏大小也有相同结果。尽管斋月期间肝酶的中位数和范围最低,但与禁食前和禁食后相比,差异无统计学意义。此外,无论患者有无心脏病史,左心室EF%均无显著差异。
本研究表明,如果患者继续禁食,RIF似乎不会影响β-TM的严重程度。然而,建议在更多国家开展更大样本量的进一步研究以证实这些发现。